ArticleJournal of global health2025
Incidence and costs of hospitalisation due to acute respiratory infection in adults aged over 50 years in Jiangsu, China in 2019-23: a real-world medical database analysis of 0.2 million episodes.
Article in Journal of global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute respiratory infection (ARI) poses a significant public health challenge worldwide, particularly among older adults. However, the disease and economic burden of ARI among older adults in China remained sparse. We aimed to estimate the incidence rate and medical cost of hospitalisation due to ARI among adults aged ≥50 years in Jiangsu Province, China. Methods: We analysed medical records of hospitalised episodes due to ARI from January 2019 to May 2023 from a regionally representative medical database. We estimated hospitalisation rates and the proportion of severe cases (intensive care unit admission, mechanical ventilation, or death) by sex, age group, and time period. Total direct medical cost and out-of-pocket cost were estimated in CNY. We analysed factors influencing total costs using a multivariate linear regression model. We further compared the proportion of severe cases and medical cost between those with and without selected comorbidities. Results: A total of 209 632 episodes of ARI hospitalisation were included. Over the study period, annualised ARI hospitalisation rate ranged from 1.07 to 1.83 per 1000 person-years, and varied by age, sex and region. Severe cases accounted for 6.5-10.3%. The median total direct medical cost was CNY 9027 (interquartile range (IQR) = 6118-14 886), of which 22% (IQR = 7-41) was out-of-pocket. Rural residents born a substantial out-of-pocket cost, which was even higher than their average monthly disposable income. Patients with certain comorbidities had higher medical costs despite having a similar or even lower proportion of severe cases. Conclusions: By analysing a large regionally representative medical database, we helped address the knowledge gap in the burden and cost of ARI hospitalisation in China. While highlighting the overall substantial disease burden and cost of ARI, we identified important factors such as age, sex, region, and comorbidity that influence the disease burden and cost of ARI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.